NCT01747096View on ClinicalTrials.gov

TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Patients With Gastroenteropancreatic Neuroendocrine Tumors
Interventions
DRUG

68-Ga-DOTANOC

Trial Locations (5)

44805

Institut de Cancérologie de l'Ouest, René Gauducheau, Saint-Herblain

Nantes Hospital, Saint-Herblain

49100

Angers Hospital, Angers

75018

Hôpital Bichat, Paris

92110

Hôpital Beaujon, Clichy

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT01747096 - TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors | Biotech Hunter | Biotech Hunter